Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

Pharmalot By Ed Silverman

100 lawmakers ask HHS to use controversial federal laws to combat high drug prices

The lawmakers reiterated calls to invoke march-in rights or another law that would allow the federal government to sidestep patents.

Read The Story

Pharmalot By Ed Silverman

Pharma largely failed to follow human rights principles with its Covid-19 vaccines and drugs

Descovy Truvada patient assistance program

Pharmalot By Ed Silverman

A ‘colossal financial fraud’: Gilead to get $33 million from a clinic for exploiting its HIV patient assistance program

Pharmalot By Ed Silverman

A CVS whistleblower lawsuit comes at a pivotal moment for the FTC’s probe of pharma and PBMs

Exclusive By Ed Silverman

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

All Coverage

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and U.S. strike $3.2 billion deal for Covid vaccine; marketing of morning-after pills shifts to mail-order options

Pharmalot By Elizabeth Cooney

Pharmalittle: FDA panel urges revamped Covid boosters; White House to widen access to monkeypox vaccine

Pharmalot By Ed Silverman

Pharmalittle: Retailers ration contraceptive pills as demand spikes; Supreme Court rules doctors must knowingly misprescribe opioids to be convicted

Pharmalot By Ed Silverman

Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Sarepta halts a Duchenne clinical trial over safety; Why the CVS Health whistleblower lawsuit comes at a pivotal moment

Pharmalot By Ed Silverman

Pharmalittle: Senate bill would allow insulin makers to lock in profits; GSK, Novartis pledge funds for diseases that mostly affect the poor

Pharmalot By Ed Silverman

Industry-funded studies on cost-effectiveness often favor pricier drugs, study finds

Pharmalot By Ed Silverman

Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal

Pharmalot By Ed Silverman

Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate

Pharmalot By Ed Silverman

Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe

Pharma By Jessica Davis Plüss

European researchers seek greater stake in drug development in bid to improve access

Pharmalot By Ed Silverman

Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy

Pharmalot By Ed Silverman

European Commission investigates Vifor for ‘disparaging’ its only rival in iron deficiency market

Pharmalot By Ed Silverman

Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FTC warns pharma and PBMs about rebate schemes; WTO reaches Covid vaccine patent waiver deal

Pharmalot By Ed Silverman

WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy

Pharmalot By Ed Silverman

FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes

Pharmalot By Ed Silverman

Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results

Pharma By Adam Feuerstein

A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer’s disease

Health By Akila Muthukumar

Popular drug may have new benefit in men with diabetes, but not women, study shows

Pharmalot By Ed Silverman

Pharmalittle: FDA panel to review Covid shots for young children; Shionogi to license antibiotic to dozens of poor countries

Pharmalot By Ed Silverman

100 lawmakers ask HHS to use controversial federal laws to combat high drug prices

Pharma largely failed to follow human rights principles with its Covid-19 vaccines and drugs

A ‘colossal financial fraud’: Gilead to get $33 million from a clinic for exploiting its HIV patient assistance program

A CVS whistleblower lawsuit comes at a pivotal moment for the FTC’s probe of pharma and PBMs

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

All Coverage

Pharmalittle: Pfizer and U.S. strike $3.2 billion deal for Covid vaccine; marketing of morning-after pills shifts to mail-order options

Pharmalittle: FDA panel urges revamped Covid boosters; White House to widen access to monkeypox vaccine

Pharmalittle: Retailers ration contraceptive pills as demand spikes; Supreme Court rules doctors must knowingly misprescribe opioids to be convicted

Pharmalittle: Abortion pills will be at center of legal battles; Gilead reaches $33 million settlement over patient assistance programs

Up and down the ladder: The latest comings and goings

Pharmalittle: Sarepta halts a Duchenne clinical trial over safety; Why the CVS Health whistleblower lawsuit comes at a pivotal moment

Pharmalittle: Senate bill would allow insulin makers to lock in profits; GSK, Novartis pledge funds for diseases that mostly affect the poor

Industry-funded studies on cost-effectiveness often favor pricier drugs, study finds

Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal

Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate

Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe

European researchers seek greater stake in drug development in bid to improve access

Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy

European Commission investigates Vifor for ‘disparaging’ its only rival in iron deficiency market

Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs

Up and down the ladder: The latest comings and goings

Pharmalittle: FTC warns pharma and PBMs about rebate schemes; WTO reaches Covid vaccine patent waiver deal

WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy

FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes

Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results

A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer’s disease

Popular drug may have new benefit in men with diabetes, but not women, study shows

Pharmalittle: FDA panel to review Covid shots for young children; Shionogi to license antibiotic to dozens of poor countries

FDA oversight of pharma manufacturing facilities plunges during the pandemic

Subscribe to STAT for $15 per month lorem ipsum